GFC Ltd. logo

GFC Ltd. (4506)

Market Closed
7 Aug, 05:30
TWSE TWSE
NT$
122. 50
+0.5
+0.4098%
NT$
- Market Cap
- P/E Ratio
0.11% Div Yield
29,343 Volume
0 Eps
NT$ 122
Previous Close
Add Transaction
Day Range
121.5 122.5
Year Range
110 132.5
Want to track 4506 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

4506 closed Friday higher at NT$122.5, an increase of 0.4098% from Thursday's close, completing a monthly increase of 0.823% or NT$1. Over the past 12 months, 4506 stock gained 2.5105%.
4506 pays dividends to its shareholders, with the most recent payment made on Aug 12, 2025. The next announced payment will be in In 1 day on Aug 12, 2026 for a total of NT$5.3.
The last earnings report, released on Mar 12, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
GFC Ltd. has completed 2 stock splits, with the recent split occurring on Oct 12, 2017.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on JPX (JPY).

4506 Chart

GFC Ltd. (4506) FAQ

What is the stock price today?

The current price is NT$122.50.

On which exchange is it traded?

GFC Ltd. is listed on TWSE.

What is its stock symbol?

The ticker symbol is 4506.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.11%.

What is its market cap?

As of today, no market cap data is available.

Has GFC Ltd. ever had a stock split?

GFC Ltd. had 2 splits and the recent split was on Oct 12, 2017.

GFC Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Toru Kimura CEO
TWSE Exchange
TW0004506001 ISIN
JP Country
4,980 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Sumitomo Pharma Co., Ltd., originally known as Sumitomo Dainippon Pharma Co., Ltd., underwent a name change in April 2022 and is well established in the pharmaceutical industry. The company, rooted in a rich history dating back to 1897, has expanded its operations beyond its headquarters in Osaka, Japan, to achieve a global footprint. This expansion encompasses key markets in North America, China, and various international locations. As a prominent player in the pharmaceutical sector, Sumitomo Pharma is committed to the discovery, development, and distribution of a wide range of products aimed at improving human and animal health. Its comprehensive portfolio includes pharmaceuticals, food ingredients and additives, veterinary medicines, and more. The company's significant role in the pharmaceutical industry is further evidenced by its strategic partnerships and collaborations with research institutions such as Keio University, RIKEN, Kyoto University, and industry counterparts like Otsuka Pharmaceutical Co., Ltd., and Roivant Sciences Ltd. Operating under the umbrella of Sumitomo Chemical Company, Limited, Sumitomo Pharma adheres to its mission of enhancing healthcare through innovation.

Products and Services

Sumitomo Pharma Co., Ltd. boasts a diverse array of products and services across several categories, underscoring its extensive contribution to the pharmaceutical and healthcare industry.

  • Pharmaceutical Products: The company's pharmaceutical portfolio addresses a wide spectrum of medical conditions, offering therapeutic agents for diseases such as Parkinson's disease, uterine fibroids, depression, type 2 diabetes, and many more. This category also encompasses advanced treatments for conditions like systemic fungal infection, hypertension, and chronic diseases including cancer, respiratory, and cardiovascular diseases.
  • Food Ingredients and Additives: Expanding beyond pharmaceuticals, Sumitomo Pharma provides a range of polysaccharides used as food ingredients and additives. This segment caters to the food industry, offering products like soups, bouillons, and other seasonings, thereby enhancing the nutritional and taste profile of various food products.
  • Chemical Product Materials: The company also engages in the manufacture and distribution of chemical materials for a variety of applications. This includes pharmaceutical excipients, personal care products, coatings, industrial materials, and electronic materials, showcasing Sumitomo Pharma's versatility and competency in chemical technologies.
  • Veterinary Medicines: Sumitomo Pharma's commitment to health extends to the animal kingdom, offering a range of veterinary medicines targeted at companion animals like dogs and cats, as well as livestock including cattle, swine, poultry, horses, and aquacultured fish. These products are designed to improve the health and well-being of animals, contributing to the broader spectrum of healthcare.

Contact Information

Address: 6-8, Doshomachi 2-chome
Phone: 81 6 6203 5321